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Abstract
To study the apoptosis and its mechanism at the fetal-maternal interface of early gestation,
localization of apoptotic cells in the implantation sites of the rhesus monkey on day 17, 19, 28 and
34 of pregnancy were first examine by using the TUNEL technique. The expression of Ki67, a
molecular marker of proliferating cells, and two apoptotic proteins, B cell lymphoma/leukaemia-2
(Bcl-2) and P53, were then studied by immunohistochemistry. Apoptotic nuclei were observed
mainly in the syncytiotrophoblast. Ki67 was confined almost exclusively to cytotrophoblasts. The
localization of Bcl-2 protein follows that of the apoptotic nuclei and its expression level increased
as the development of the placenta progressed on. P53 was detected to some extent in
cytotrophoblasts and syncytiotrophoblast covering the basal feet of the anchoring villi during the
late stage of placentation. Based on these observations, it might be suggested that Bcl-2 could be
possible to play an interesting role in limiting degree of nuclear degradation and sustaining cell
suvival in the multi-nucleated syncytiotrophoblast cells during early pregnancy, and P53 could also
be essential in regulating the trophoblastic homeostasis by controlling its proliferation or apoptosis.
Introduction
Apoptosis plays important roles in placentation and
embryonic development [1]. The cells undergoing apop-
tosis have characteristic structural changes in the nucleus
and cytoplasm. The nuclear disintegration involves DNA
cleavage into oligonucleosomal length DNA fragments [2-
4], and the DNA fragments can be detected by terminal
deoxynucleotidyl transferase (TdT)-mediated deoxyurid-
ine triphosphate (dUTP) nick end-labelling (TUNEL)
technique. Expressions of apoptotic regulatory molecules,
such as Fas, Fas ligand, P53, and the proteins of Bcl-2 fam-
ily, have been reported in human placenta [5-8]. Bcl-2 and
P53 are two of the key players in the apoptotic signaling
cascades. Bcl-2, a proto-oncogene first discovered in
human follicular lymphoma [9], is involved in the inhibi-
tion of apoptosis and the survival of a variety of cell types
[10]. Bcl-2 protein is located in the membranes of endo-
plasmic reticulum, nuclear envelope, and mitochondria.
Over-expression of Bcl-2 suppresses apoptosis by prevent-
ing the activation of caspases that carry out the process.
P53 is well known as a tumor suppressor. It is a transcrip-
tion factor that induces apoptosis mainly through induc-
ing the expression of a batch of redox-related genes [11]
and the down-regulating Bcl-2 [12].
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studied [1,13]. However, their cellular distribution in the
implantation site at early stage of pregnancy has not been
reported. Because the monkey and the human share a very
similar implantation process in terms of timing, morpho-
logical changes, and cell types involved [14], we aimed, in
the present study, to investigate the expression, localiza-
tion of Bcl-2 and P53 in the implantation site of the rhe-
sus monkey, in order to gain some insights to the




Healthy adult male and female rhesus monkeys (Macaca
mulatta) were purchased from the monkey colony of the
Primate Research Center (PRC), Kunming Institute of
Zoology (KIZ), Chinese Academy of Sciences (CAS). All
experimental procedures were approved by the Animal
Ethics Committees of both the Institute of Zoology and
PRC. The animals were caged individually and were eval-
uated daily by visual examination of the perineum for
menses, with the onset of menses defined as Day 1 of the
menstrual cycle. Adult female monkeys with regular men-
strual cycles of approximately 28 days were chosen for this
study. Female monkeys on Day 11 of their menstrual cycle
were caged with a male monkey of proven fertility from
previous mating for 3 days. Vaginal smears were examined
the next morning for the presence of sperm. The day when
the smear was detected as positive for sperms was desig-
nated as Day 1 of pregnancy (D1). The presence of a con-
ceptus was confirmed by ultrasound examination. The
monkeys were anesthetized by pentobarbital sodium (3
animals each group), and the uteri were removed surgi-
cally from early villous to villous placenta stages: on D17,
D19, D28 and D34 of pregnancy respectively and cut into
pieces, the specimens were quickly washed in cold phos-
phate-buffered saline (PBS) to remove adherent blood,
then placed in cold 4% paraformaldehyde fixative for 16
h at 4°C and further processed through graded dehydra-
tion, clearing and embedding in paraffin for immunohis-
tochemistry and TUNEL assay. Part of the specimen was
cryopreserved at -70°C for Western blot analysis.
Reagents
Primary antibodies including rabbit anti-human P53 (SC-
6243) and mouse anti-human Bcl-2 (SC-7382) were
obtained from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). Their quality and specificity were confirmed by the
result of the Western blot analysis of D34 placental pro-
teins (Figure 1). Rabbit anti-human cytokeratin
(ZA0070), mouse anti-human actin (ZA0001), and
mouse anti-Ki67 (ZM0166) were purchased from Zymed
laboratories (San Francisco, CA, USA). Biotin labeled sec-
ondary antibodies, alkaline phosphatase (AP) conjugated
avidin, horseradish peroxidase (HRP) conjugated goat
anti-rabbit IgG, HRP-conjugated horse anti-mouse IgG,
and AP substrates "Vector-red" were from Vector Labora-
tories (Burlingame, CA, USA). Digoxigenindideoxy
(DIG)-11-dUTP, TdT, blocking reagent, AP-conjugated
anti-DIG antibody and 5-bromo-4-chloro-3-indoxyl
phosphate/nitro-blue tetrazolium chloride (BCIP/NBT)
were purchased from Roche-Boehringer-Mannheim
(Mannheim, Germany). Proteinase K was purchased from
Merck-Schuchardt (Darmstadt, Germany). Levamisole
were purchased from Sigma-Aldrich (St Louis, MO, USA).
SuperSignal® West Pico substrate was from PIERCE Bio-
technology (Rockford, IL, USA).
Western blot
Western blot was done as previously described [15] with
slight modifications to verify the cross-reactive specificity
of the antibodies with the monkey tissue. The tissue of
implantation sites on D34 of pregnancy was homoge-
nized and the supernatant (50 µg) from centrifugation
was run on a 10% SDS-PAGE gel under reduced condi-
tions. After being transferred to the polyvinylidene difluo-
ride membrane, individual lanes were cut and blocked
with 5% nonfat milk/PBS for 1 h, followed by incubation
at 20°C for 1 h with the primary antibodies (IgG, 0.2 µg/
ml) in 5% milk/PBS. The membranes were washed three
times, 5 min for each, in 5% milk/PBS and incubated with
HRP-conjugated horse anti-mouse IgG (0.2 µg/ml, for Bcl-
2) or HRP-conjugated goat anti-rabbit IgG (0.04 µg/ml,
for P53) in 5% milk/PBS for 1 h respectively. The
Western blot analysis of Bcl-2 and P53 for monkey tissue obtained on D34 of pregnancyFigur  1
Western blot analysis of Bcl-2 and P53 for monkey 
tissue obtained on D34 of pregnancy. Specific signals of 
Bcl-2 and P53 proteins were detected. No band was found in 
the control when antibodies were replaced with normal IgG 
of the same concentration and origin.Page 2 of 10
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each, followed by 10 min of incubation with SuperSignal®
West Pico substrate, then exposed on x-ray film. For nega-
tive controls, primary antibodies were replaced with nor-
mal IgG of the same concentration and origin.
TUNEL
Apoptotic cells were identified by using the TUNEL tech-
nique [1,16]. The procedure was slightly modified based
on Gao et al. [17] as the following. Deparaffinized and
hydrated 4 µm sections were first treated with 10 µg/ml
proteinase K at 37°C for 20 min, and then subjected to 3'-
end-labelling of the DNA with 1 µM DIG-11-dUTP and 1
U/µl TdT at 37°C for 1 h. The sections were washes three
times in Tris buffer, and incubated with blocking buffer
(100 mM Tris, 150 mM NaCl, pH 7.5, and 1% blocking
reagent) for 30 min at room temperature. Next, sections
were incubated with the primary AP-conjugated anti-DIG
antibody (1:500 in 1% blocking reagent, 100 mM Tris,
and 150 mM NaCl, pH 7.5) at room temperature for 2 h,
and then washed with Tris buffer. Staining was developed
using the standard substrates NBT (337.5 µg/ml) and
BCIP (175 µg/ml). Negative controls were similarly proc-
essed with the omission of TdT.
Immunohistochemistry
Serial 4 µm sections of tissue were deparaffinized and
rehydrated through degraded ethanol. Antigen retrieval
was performed by incubating the sections in 0.01 M cit-
rate buffer (pH 6.0) at 98°C for 20 min followed by cool-
ing at room temperature for 20 min. Non-specific binding
was blocked with 5% (v/v) normal goat serum in PBS for
1 h. The sections were incubated with primary antibodies
specific for P53 (1 µg/ml), Bcl-2 (2 µg/ml) or Ki67 (2 µg/
ml) respectively in 2% goat serum overnight at 4°C. Sec-
tions were then washed three times with PBS (10 min
each) and incubated with biotinylated secondary anti-
body (2 µg/ml) at RT for 30 min. 3 × 10 min successive
washes were followed by incubation with avidin-AP com-
plex (1:200, RT, 20 min). Sections were developed with
standard substrates (337.5 µg/ml NBT and 175 µg/ml
BCIP) or Vector Red AP substrates according to the manu-
facturer's protocol after another three washes. Endog-
enous AP activity was inhibited by supplement of 1 mM
levamisole into substrate. The sections stained with Vector
Red substrates were counter-stained using haematoxylin.
Sections incubated with normal IgG instead of primary
antibody served as negative controls.
A double immunostaining technique using the antibodies
to cytokeratin and actin was performed to localize the
extravillous endovascular trophoblast cells. De-paraffin-
ized sections were incubated with 3% H2O2 in methanol
for 10 min at room temperature to quench endogenous
peroxidase after antigen retrieval treatment as described
above. To detect the cytokeratin signal, the sections were
washed (3 × 10 min in PBS), blocked for nonspecific sig-
nals, incubated sequentially with primary anti-human
cytokeratin anbibody (1 µg/ml, RT, 1 h), secondary
biotinylated goat anti-rabbit IgG (2 µg/ml, RT, 30 min),
and avidin-peroxidase complex (1:200, RT, 20 min), and
developed with DAB substrate solution in a similar way as
described above. To detect actin signal, the procedure was
repeated one more time with anti-human actin antibody
(1 µg/ml, RT, 2 h) as primary antibody, AP conjugated
horse anti-mouse IgG (1 µg/ml, RT, 40 min) as secondary
antibody, and Vector Red developing AP substrate. As a
result, the trophoblast cells were labeled brown and the
blood vessel wall red.
Microscopic assessment
Placental samples from three individual monkeys for each
group were analyzed. Experiments were repeated at least
three times, and one representative from at least three
similar results was presented. The mounted sections were
examined using a Nikon microscope. For Ki67, the per-
centages of immunoreactive cells were assessed on at least
2000 cells in each tissue section; For TUNEL, the percent-
ages of positive nuclei were assessed out of at least 2000
nuclei in each tissue section; For assessment of Bcl-2 stain-
ing intensity in cells of different compartments, semi-
quantitative subjective scoring was performed by three
blinded investigators using a 4-scale system with "-"= nil;
"+/-"= weak; "+" = moderate; and "++" = strong as
described by Yue et al. [18].
Results
Apoptosis in implantation site of early pregnancy
The TUNEL technique was used to identify cell types that
underwent apoptosis in the implantation site of rhesus
monkey on D17, D19, D28 and D34 of pregnancy. On
D17 and D19, apoptotic nuclei were observed in the syn-
cytiotrophoblast layer covering the basal feet of the
anchoring villi (Figure 2 A, B, arrowhead) and in the vil-
lous stromal cells (Figure 2 A, arrow), but not in the
cytotrophoblasts. The positive nuclei in the syncytiotro-
phoblast was only about 0.06%. On D28 and D34, the
apoptotic nuclei were present in the syncytiotrophoblast
covering the villi (Figure 2 C, D), in the villous stromal
cells (Figure 2 C, D, arrow), in the syncytiotrophoblast
layer covering the basal feet of the anchoring villi (Figure
2 E), and in the cytotrophoblasts within the cell columns
(Figure 2 F). On D28, the percentage of TUNEL-positive
nuclei in the syncytiotrophoblast was 0.21%. As preg-
nancy progresses, the percentage increased to 0.34% on
D34. In maternal compartment, a lot of apoptotic nuclei
were detected in the stromal cells (Figure 2 G) and glan-
dular epithelium (Figure 2 H).Page 3 of 10
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Ki67 is a protein expressed in cycling cells from G1 to M
phases and is widely used as a roliferative marker (19, 20).
As shown in Figure 3, Ki67 was expressed in the cytotro-
phoblasts and the villous stromal cells, but not in the syn-
cytiotrophoblasts. As pregnancy progresses, the
percentage of Ki67-positive cytotrophoblast cells lining
the villi decreased from more than 85% on D17 to less
than 25% on D34 (Panel A-D, and E, F for a higher mag-
nification). However, the cytotrophoblasts at the proxi-
mal tip of cell columns remained highly proliferative
(more than 70%) at all stages (Panel G and H).
Bcl-2 expression in implantation site at early pregnancy
In order to study the mechanisms of the apoptosis
observed at the fetal-maternal interface, the expression of
Bcl-2 was investigated by using immunohistochemistry.
At the early stages of placentation (D17, D19), Bcl-2 was
only detected in the syncytiotrophoblast covering the cell
columns (Figure 4, A and 4B) and the extravillous cytotro-
phoblast (Figure 4C, arrow). At the later stages (D28,
Apoptosis detected by TUNEL at the implantation sites of the rhesus monkey on D17 (A), D19 (B), D28 (C, G) and D34 (D, E, F, H) of gesta ionigure 2
Apoptosis detected by TUNEL at the implantation sites of the rhesus monkey on D17 (A), D19 (B), D28 (C, G) 
and D34 (D, E, F, H) of gestation. Apoptotic nuclei were stained dark. Arrowhead and arrow in panel A – D indicated the 
nuclei of syncytiotrophoblast and villous stromal cells respectively. The insets in C and D showed the positive nuclei under a 
higher magnification. Note the syncytiotrophoblast layer covering the basal feet of the anchoring villi in E and the cell columns 
in F. G and H represent the stromal cells and glandular epithelial cells respectively in the endometrium. I was the negative con-
trol. St, syncytiotrophoblast; CT, cytotrophoblast; Vi, placental villi. Scale bars represent 50 µm.Page 4 of 10
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4,D and 4E), the villous stromal cells (Figure 4F, arrow),
and the extravillous endovascular trophoblast cells (Fig-
ure 4G), the fetal origin of these cells were indicated by
the anti-cytokeratin antibody staining (Figure 4 G inset,
brown), and the vascular wall was stained by anti-actin
antibody (red). The pattern of Bcl-2 expression in the syn-
cytiotrophoblast was similar to that of the apoptotic
nuclei distribution (Figure 2). In the maternal compart-
ment, Bcl-2 could be detected in some stromal cells (Fig-
ure 4H). Notably, the cytotrophoblasts lining the villi,
within the cell columns, and the glandular epithelia were
negative for Bcl-2 staining. The semi-quantitative expres-
sion level of Bcl-2 in different cell types at the various
stages was summarized in Table 1. A gradual increase of
Bcl-2 staining was observed in the syncytiotrophoblast as
gestation advances.
P53 expression in implantation site at early pregnancy
The expression profile of P53 was also acquired by using
the immunohistochemistry. On D17 and D19, the expres-
sion of P53 was only confined to a small number of nuclei
in the syncytiotrophoblast (Figure 5,A,B). On D28 and
D34, its expression was observed not only in the
The proliferating activity revealed by Ki-67 immunostaining at implantation sites of the rhesus monkey on D17 (A, E, G), D19 (B), D28 (C) a d D34 (D, F, H) of gestationFigure 3
The proliferating activity revealed by Ki-67 immunostaining at implantation sites of the rhesus monkey on D17 
(A, E, G), D19 (B), D28 (C) and D34 (D, F, H) of gestation. Panels A-D were under a lower magnification. Ki-67 protein 
was stained red, and nuclei blue. E and F were the placental villi under a higher magnification. G and H were the anchoring villi 
under a higher magnification. Vi, placental villi. ST, syncytiotrophoblast. CT, cytotrophoblast. Sc, stromal cell. En, endometrium. 
Scale bars represent 100 µm.Page 5 of 10
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Reproductive Biology and Endocrinology 2005, 3:4 http://www.rbej.com/content/3/1/4Immunohistochemical staining for Bcl-2 at implantation sites of the rhesus monkeyFigure 4
Immunohistochemical staining for Bcl-2 at implantation sites of the rhesus monkey. Bcl-2 staining is red, and 
nuclear counterstain blue. A, villous plancenta on D17. B, villous plancenta on D19. C, extravillous trophoblast cells in the basal 
plate of D17. D, villous plancenta on D28. E, villous plancenta on D34. F, villous plancenta on D34 under a higher magnification. 
G, the extravillous endovascular trophoblast cells; in the inset, the fetal origin of these cells was confirmed by anti-cytokeratin 
antibody (brown), and their position within the vascular wall was confirmed by anti-actin antibody staining (red). H, decidua. I, 
negative control. Vi, placental villi. ST, syncytiotrophoblast. CT, cytotrophoblast. Sc, stromal cells. Ge, glandular epithelium. 
Evc, extravillous cytotrophoblast. Scale bars represent 50 µm.
Table 1: Semi-quantitative assessment of the immunohistochemical staining of Bcl-2 in the placenta of rhesus monkey.
D17 D19 D28 D34
Syncytiotrophoblast lining the villi +/- +/- ++ ++
Syncytiotrophoblast covering the cell column + + ++ ++
cytotrophoblast lining the villi - - - -
extravillous cytotrophoblast + + + +Page 6 of 10
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of cytotrophoblasts lining the villi (Figure 5E) and within
proximal tip of cell columns (Figure 5F) where a prolifer-
ative activity was high as indicated by Ki67 staining (Fig-
ure 3). Clustered P53-positive nuclei were seen in the
syncytiotrophoblast covering the basal feet of the anchor-
ing villi (Figure 5G), coincident well with the strong apop-
tosis detected by TUNEL (Figure 2E). P53 was also
expressed in some stromal cells (Figure 5H) of the uterine
endometrium.
Discussion
For the first time in present study, we investigated the
expression of Bcl-2 and P53 in relation to apoptosis at the
fetal-maternal interface of rhesus monkey at the very early
stages (D17-D34) of gestation. Villous trophoblasts
consist of cytotrophoblasts and syncytiotrophoblast.
While cytotrophoblasts possess a brisk mitotic activity
during the first trimester of gestation in human, the syncy-
tiotrophoblast is incapable of cell division despite of a
metabolic activity [1]. This fact implies that cell
proliferation is differently regulated in these two cell
Immunohistochemical staining for P53 at implantation sites of the rhesus monkey on D17 (A), D19 (B), D28 (C, H), and D34 (D, E, F, G) f g stationFigure 5
Immunohistochemical staining for P53 at implantation sites of the rhesus monkey on D17 (A), D19 (B), D28 
(C, H), and D34 (D, E, F, G) of gestation. P53 was stained dark in nuclei. A-D were villous placenta under a lower 
magnification. The inset of panel A shows the staining in the syncytiotrophoblast covering the basal feet of the anchoring villi 
under a higher magnification. E, staining in villous placenta under a higher magnification. F, staining in cell columns. G, syncytio-
trophoblast covering the basal feet of the anchoring villi under a higher magnification. H, the endometrium with arrows indicat-
ing stromal cells. ST, syncytiotrophoblast. CT, cytotrophoblast. Scale bars represent 50 µm.Page 7 of 10
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going apoptosis in the first trimester are controversial
[1,21,22]. Our results further cleared that the apoptotic
nuclei were distributed mainly in the syncytiotrophoblast
at the early stages and in the cytotrophoblasts within the
cell columns at later stages of pregnancy.
In our previous study, Bax expression was found at the
Fetal-Maternal Interface of Rhesus Monkey [17]. Bax is a
Bcl-2 family member that promotes cell death susceptibil-
ity, possibly by countering the effect of Bcl-2 on cell sur-
vival through heterodimer interaction. Bax to Bcl-2
"rheostat" may be a critical factor in regulating apoptosis
in multiplicate tissues. As shown in Figure 6, Bax was
found expressed in the placenta and glandular epithelium
of endometrium and all kinds of cells in placental villi,
and no obvious change was observed between different
time points from D17 to D34 in placental villi. Therefore,
we speculated that Bcl-2 may play a more important role
on controlling the apoptosis in placental villi. The diffu-
Immunohistochemical staining for Bax at implantation sites of the rhesus monkey on D28Figure 6
Immunohistochemical staining for Bax at implantation sites of the rhesus monkey on D28. Bax staining is brown, 
and nuclear counterstain blue. A, villous plancenta, positive staining was found in all the cells. B, endometrium, glandular epithe-
lium was positive for Bax staining. Vi, placental villi. Ge, glandular epithelium.Page 8 of 10
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from the first trimester human placenta has been reported
recently [7,23-25]. Our observation on the Bcl-2 expres-
sion in syncytiotrophoblast at later stages (D28-D34)
agreed well with these data. As shown in this study,
although Bcl-2 was expressed, apoptotic nuclei still
exsisted in the same region. This phenomenon implies
that the expression of Bcl-2 is not sufficient to completely
inhibit the apoptosis in the syncytiotrophoblast. There-
fore, the role of Bcl-2 here becomes an interesting ques-
tion. Multiple nuclei sharing the same cytoplasm is a
morphological characteristic of syncytiotrophoblast. In
such cells, the apoptotic signal may be transmitted from
one nuclear to another, and cause a spontaneous abor-
tion. Therefore, the number of nuclei undergoing apopto-
sis in the syncytiotrophoblast should be limited by some
mechanism in order to ensure normal embryo develop-
ment in normal pregnancy [1]. We speculate that Bcl-2
may be included in this mechanism. The major role of
apoptosis-associated Bcl-2 expression in the syncytiotro-
phoblast might be to limit the nuclear degradation to a
special area and inhibit the spread of cell apoptosis signals
to the other nuclei sharing the same cytoplasm, thus sus-
tain cell survival in these multi-nucleated cells. Toki et al
has also suggested that Bcl-2 might play a major role in
avoiding the possible excessive nuclear degradation in
syncytiotrophoblast [26]. Further studies, however, are
needed to prove this speculation. The immunostaining for
Bcl-2 was also detected in part of the extravillous and
endovascular cytotrophoblast in our study. These sub-
types of cytotrophoblast lost the capacity of proliferation
(Ki-67-negative), but they did not undergo apoptosis
(negative in TUNEL assay). Therefore, we hypothesize that
Bcl-2 may also participate in regulation of the extravillous
trophoblast apoptosis by stimulating the cellular survival.
P53 was partly identified in some nuclei of the syncytio-
trophoblast with the same position of apoptotic nuclei, in
the basal feet of the anchoring villi in particular, but it is
not clear whether the P53 was co-localized with the apop-
totic signals. Activation of P53 in some cell types leads to
either the cessation of cell growth or apoptosis [27].
Therefore, P53 protein might be related to cell cycle arrest
or apoptosis in syncytiotrophoblast during early stage of
placentation. Low level of P53 staining was detected in the
cytotrophoblasts during the earlier stages of gestation
(D17 and D19). However, at the later stages (D28 and
D34), the expression was observed predominantly in the
nuclei of cytotrophoblasts. The presence of P53 in cytotro-
phoblast in the primate was consistent with that observed
in the human first trimester placenta [8]. Indeed, the
TUNEL staining showed that the apoptosis seldom hap-
pened in the cytotrophoblast, with the exception of
cytotrophoblast at proximal tip of cell columns during
later stages of placentation (D28, D34) where a high pro-
liferative activity and P53 expression were detected. This
finding supports the hypothesis that a physiological
upregulation of the P53 tumour suppressor gene might be
a mechanism for controlling excessive trophoblastic pro-
liferation in normal placentation [26,28].
It is known that early pregnancy is unique in its methods
of cell proliferation control, the existing data suggest that
some growth factors and transcription factors from the
embryo and endometrium, such as CSF-1, VEGF, and
transcription factors of the helix-loop-helix family, pro-
vide at least part of this control [29]. In addition, other
studies found maternal age and some diseases, such as
diabetes can also influence the apoptotic and proliferative
activities in trophoblast cells [30,31]. Further investiga-
tions are required to uncover which endocrine event regu-
lates the expression of Bcl-2 and P53.
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